LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma

FEBS Journal

Volumn 281, Issue 13, 2014, Pages 3004-3018

  Zhao, Yi ^a   Pang, Tian Yun ^a   Wang, Yan ^a   Wang, Sen ^a   Kang, Hai Xian ^a   Ding, Wei Bin ^a   Yong, Wei Wei ^a   Bie, Yan Hong ^a   Cheng, Xiao Guang ^a   Zeng, Chao ^a   Yao, Yun Hong ^a   Li, Qing ^b   Hu, Xin Rong ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

eIF4E; invasion; LMP1; nasopharyngeal carcinoma; proliferation

Indexed keywords

INITIATION FACTOR 4E; LATENT MEMBRANE PROTEIN 1;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; HUMAN; HUMAN CELL; LATENT MEMBRANE PROTEIN 1 GENE; METASTASIS; NASOPHARYNX CARCINOMA; ONCOGENE C MYC; PRIORITY JOURNAL; STABLE TRANSFECTION; TRANSCRIPTION REGULATION; TRANSIENT TRANSFECTION; TRANSLATION INITIATION; TUMOR GROWTH; TUMOR INVASION; TUMOR PROMOTION;

EUKARYOTA; HUMAN HERPESVIRUS 4;

EIF4E; INVASION; LMP1; NASOPHARYNGEAL CARCINOMA; PROLIFERATION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPSTEIN-BARR VIRUS INFECTIONS; EUKARYOTIC INITIATION FACTOR-4E; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HOST-PATHOGEN INTERACTIONS; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; VIRAL MATRIX PROTEINS;

EID: 84903819310     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12838     Document Type: Article

References (30)

1. Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, &, Raab-Traub N, (2006) LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25, 288-297.
2. Vaysberg M, Lambert SL, Krams SM, &, Martinez OM, (2009) Activation of the JAK/STAT pathway in Epstein-Barr virus-associated post transplant lymphoproliferative disease: role of interferon-gamma. Am J Transplant 9, 2292-2302.
3. Zhao Y, Wang Y, Zeng S, &, Hu X, (2012) LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol 65, 41-45.
4. Fischer PM, (2009) Cap in hand: targeting eIF4E. Cell Cycle 8, 2535-2541.
5. Jia Y, Polunovsky V, Bitterman PB, &, Wagner CR, (2012) Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target. Med Res Rev 32, 786-814.
6. De Benedetti A, &, Harris AL, (1999) eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 31, 59-72.
7. De Benedetti A, &, Graff JR, (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23, 3189-3199.
8. Wu M, Liu Y, Di X, Kang H, Zeng H, Zhao Y, Cai K, Pang T, Wang S, Yao Y, et al,. (2013) EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma. Med Oncol 30, 400.
9. Zhang J, &, Zhang WY, (2005) Expression of eIF-4E, HER-2 and its correlation with LMP-1 and PCNA in nasopharyngeal carcinoma. Chinese J Diagn Pathol 12, 211-213.
10. Soni V, Cahir-McFarland E, &, Kieff E, (2007) LMP1 TRAFficking activates growth and survival pathways. Adv Exp Med Biol 597, 173-187.
11. Lin CJ, Cencic R, Mills JR, Robert F, &, Pelletier J, (2008) c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res 68, 5326-5334.
12. Ma X, Yang L, Xiao L, Tang M, Liu L, Li Z, Deng M, Sun L, &, Cao Y, (2011) Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-kappaB regulated ATM expression. PLoS One 6, e24647.
13. Qiu QC, Hu B, He XP, Luo Q, Tang GH, Long ZF, Chen ZC, &, He XS, (2012) STGC3 inhibits xenograft tumor growth of nasopharyngeal carcinoma cells by altering the expression of proteins associated with apoptosis. Genet Mol Biol 35, 18-26.
14. Chen H, Hutt-Fletcher L, Cao L, &, Hayward SD, (2003) A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 77, 4139-4148.
15. You X, Yang YC, Ke X, Hong SL, &, Hu GH, (2013) Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes. Otolaryngol Head Neck Surg 150, 251-258.
16. Wang C, Deng X, Li X, Gu H, Yi W, Weng X, Xia L, &, Cao Y, (2002) Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi 24, 9-13. [in Chinese].
17. Yang J, Deng XY, Deng L, Din GL, Gu HH, Yi W, &, Cao Y, (2003) Epstein-Barr virus LMP1 activates human telomerase transcription via c-myc expression. Chinese J Virol 19, 240-244.
18. Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, Lu Z, Sun L, &, Cao Y, (2010) STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer 46, 2996-3006.
19. Talaty P, Emery A, &, Everly DN Jr, (2011) Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation. Virol J 8, 414.
20. Tudor CS, Dawson CW, Eckhardt J, Niedobitek G, Buttner AC, Seliger B, Hartmann A, &, Buettner M, (2012) c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells. Br J Cancer 106, 1980-1988.
21. Xi J, &, Zhang J, (2006) Expression of eIF4E and HER-2 in nasopharyngeal carcinoma. J Guiyang College Trad Chinese Med 28, 55-57.
22. Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, &, Peng Y, (2006) Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. Int J Oncol 29, 595-603.
23. Endo K, Kondo S, Shackleford J, Horikawa T, Kitagawa N, Yoshizaki T, Furukawa M, Zen Y, &, Pagano JS, (2009) Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene 28, 1725-1735.
24. Gargouri B, Nasr R, Mseddi M, Benmansour R, &, Lassoued S, (2011) Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines. Lipids Health Dis 10, 111.
25. Kanda T, Shibata S, Saito S, Murata T, Isomura H, Yoshiyama H, Takada K, &, Tsurumi T, (2011) Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems. PLoS ONE 6, e27758.
26. Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, &, Kieff E, (1998) Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol 72, 7900-7908.
27. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, et al,. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
28. Chen J, Hu CF, Hou JH, Shao Q, Yan LX, Zhu XF, Zeng YX, &, Shao JY, (2010) Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma. J Transl Med 8, 30.
29. Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E, &, Becerra C, (2003) Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9, 931-946.
30. Li WG, Yuan YZ, Qiao MM, &, Zhang YP, (2012) High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells. World J Gastroenterol 18, 2630-2639.